Designed to transplant more organs
and improve outcomes
OrganOx metra is transforming liver transplantation, enabling functional assessment of donor organs prior to transplantation, reducing early allograft dysfunction and improving transplantation logistics, to the benefit of both transplant recipients and hospitals.1—4
With the OrganOx metra, the donor liver is continuously perfused with oxygenated blood, medications and nutrients at normal body temperature and near physiological pressures and flows. The metra is fully automated, easy-to-use and can preserve the donor organ in a functional state for up to 24 hours.1, †
Supporting transplant teams to save lives by making every donated organ count
Introducing the OrganOx metra. Simple to set up, fully automated, easy-to-use and transportable:
Explore the normothermic machine perfusion scientific and clinical evidence base
Scientific and clinical evidence-
12th November 2024
OrganOx and eGenesis Announce Exclusive Clinical Co-Development Agreement for Treatment of Patients with Liver Failure in the Acute Setting
Read more -
2nd October 2024
OrganOx metra® System Approved for Liver Transplantation in Canada
Read more -
29th May 2024
OrganOx CTO and co-founder Prof. Constantin Coussios elected Fellow of the UK’s Academy of Medical Sciences
Read more
-
12 - 17 Sep 2020
TTS Annual Congress
Read more -
22 - 25 Jun 2020
AOPO Annual Meeting
Read more -
30 - 30 May 2020
ATC Congress
Read more
References: 1. As demonstrated by a reduction in in Early Allograft Dysfunction from 30% (static cold storage) to 10% (metra). Nasralla D et al. Nature 2018; 557(7703):50–56. 2. Mergental H et al. Hepatology 2018; 68(1):(Suppl). 3. NICE Interventional procedures guidance (IPG636). Available at: https://www.nice.org.uk/guidance/ipg636. 4. Bral M et al. Liver Transpl 2019; 25(6):848–858.
† Disclaimer: metra® is FDA-approved for normothermic liver perfusion in the United States and can preserve the donor organ in a functional state for up to 12 hours.
UK/US MD-040-1-1 - September 2022